An investor-focused analysis of major shifts in the financial services landscape as...
Technicals for GlaxoSmithKline Pharmaceuticals Limited
By MusingTheNews
2025-12-15 20:35
Overall Technical outlook
Price Summary
GlaxoSmithKline Pharmaceuticals Limited's stock started the year at 2587.7, climbed to a high of 2608.9, fell to 2571.0, and closed -0.37% lower at 2578.1, with 25785 shares traded on 2025-12-15. The stock's highest price in the past 52 weeks is 3466.2, while its lowest price during the same period is 1956.2. 4 analysts estimate that the future price of GLAXO will fall between 2500.0 and 3500.0, with an average price expectation of approximately 3003.25.
Technicals
Support and Resistance: The current price of 2578.1 for GLAXO finds support at 2509.0 and resistance at 2588.7. These levels define a range in which the price might oscillate, with 2509.0 as a potential support and 2588.7 as a resistance level. Support/Resistance for GLAXO
Aroon: The AROON is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play. Aroon chart for GlaxoSmithKline Pharmaceuticals Limited
Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment. Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited
Parabolic SAR: The PSAR continues to signal a bullish outlook, establishing a key support level that reinforces the market's upward momentum. This support could serve as a base for continued gains, suggesting that the bullish trend is likely to persist. Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited
Stochastic: The stochastic indicator for GlaxoSmithKline Pharmaceuticals Limited shows the K-line below the D-line but still above 80, hinting at the possible onset of a bearish price move. This could indicate that the market's recent strength is waning, with a potential downturn on the horizon. Traders should keep an eye on this development for further signs of weakness. Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited
Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for GLAXO. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move. Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited
Analyzing the technical indicators of a company, such as stock price and trading volume, requires first understanding its fundamentals. These fundamentals include profitability, growth potential, and market position. Furthermore, knowing the broader industry trends and competitive landscape provides critical context. When both the company's internal data and the external environment are considered, it allows for more meaningful conclusions about the company's technical performance and future trajectory.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An in-depth article analysing the Federal Reserve’s December 2025 rate cut and...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.